Genentech: Baris Bingol

Por um escritor misterioso

Last updated 06 julho 2024

I am proud to be part of the scientific team at Genentech that values scientific excellence above all to fuel therapeutic programs for patients in need.

The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy

Ben Laufer

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies: Molecular Therapy - Nucleic Acids

Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity

Ubiquilin1 promotes antigen-receptor mediated proliferation by eliminating mislocalized mitochondrial proteins

Genentech: Corey Bakalarski Senior Principal Scientist, Bioinformatics, Microchemistry, Proteomics, Lipidomics and Next-Generation Sequencin

Baris BINGOL, Genentech, California, Department of Neuroscience

mito911 on X: Welcome our next @mito911_ speaker Baris Bingol @genentech on 17th Apr, 8am PDT! #Parkinsonsdisease #OrganelleQualityControl Registration link below ⤵️ / X